Research Article
Downregulation of LEMD1-AS1 and Its Influences on the Diagnosis, Prognosis, and Immune Infiltrates of Epithelial Ovarian Cancer
Table 2
Univariate and multivariate analyses of prognostic factors in EOC patients.
| Characteristics | Total () | Univariate analysis | Multivariate analysis | Hazard ratio (95% CI) | value | Hazard ratio (95% CI) | value |
| FIGO stage | 374 | | | | | Stage I & stage II | 24 | Reference | | | | Stage III | 293 | 2.045 (0.905-4.621) | 0.085 | 2.255 (0.815-6.241) | 0.118 | Stage IV | 57 | 2.495 (1.057-5.889) | 0.037 | 2.441 (0.839-7.100) | 0.101 | Primary therapy outcome | 307 | | | | | PD | 27 | Reference | | | | SD | 22 | 0.441 (0.217-0.895) | 0.023 | 0.443 (0.213-0.918) | 0.029 | PR | 42 | 0.652 (0.384-1.107) | 0.113 | 0.598 (0.341-1.049) | 0.073 | CR | 216 | 0.152 (0.093-0.247) | <0.001 | 0.150 (0.090-0.251) | <0.001 | Race | 364 | | | | | Asian & Black or African American | 37 | Reference | | | | White | 327 | 0.637 (0.405-1.004) | 0.052 | 0.711 (0.419-1.206) | 0.206 | LEMD1-AS1 | 377 | | | | | Low | 188 | Reference | | | | High | 189 | 0.757 (0.585-0.981) | 0.035 | 0.866 (0.640-1.170) | 0.348 | Age | 377 | | | | | ≤60 | 206 | Reference | | | | >60 | 171 | 1.355 (1.046-1.754) | 0.021 | 1.421 (1.049-1.925) | 0.023 |
|
|